Ignite Creation Date:
2024-05-06 @ 10:05 AM
Last Modification Date:
2024-10-26 @ 12:24 PM
Study NCT ID:
NCT03155997
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-26
First Post:
2017-05-15
Brief Title:
Endocrine Therapy With or Without Abemaciclib LY2835219 Following Surgery in Participants With Breast Cancer
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-12
Start Date Type:
ACTUAL
Primary Completion Date:
2020-03-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2029-05-28
Completion Date Type:
ESTIMATED
First Submit Date:
2017-05-15
First Submit QC Date:
May 15 2017
Study First Post Date:
2017-05-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2021-04-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-30
Last Update Post Date:
2024-06-26
Last Update Post Date Type:
ACTUAL